BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27840891)

  • 1. The phytogestrogenic stilbenes, arachidin-1 and resveratrol, modulate regulatory T cell functions responsible for successful aging in aged ICR mice.
    Weng BB; Lin WS; Chang JC; Chiou RY
    Int J Mol Med; 2016 Dec; 38(6):1895-1904. PubMed ID: 27840891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells.
    Yang Y; Paik JH; Cho D; Cho JA; Kim CW
    Int Immunopharmacol; 2008 Apr; 8(4):542-7. PubMed ID: 18328445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
    Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
    J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.
    Wang B; Sun J; Li X; Zhou Q; Bai J; Shi Y; Le G
    Nutr Res; 2013 Nov; 33(11):971-81. PubMed ID: 24176237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
    Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
    J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low 17β-estradiol Levels Are Better Inducers of Regulatory Conditioned T Cells In-Vitro.
    Fatemi R; Mirzadegan E; Vahedian Z; Zarnani AH; Jeddi-Tehrani M; Idali F
    Iran J Immunol; 2017 Jun; 14(2):159-171. PubMed ID: 28630386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuftsin-derived T-peptide prevents cellular immunosuppression and improves survival rate in septic mice.
    Gao YL; Chai YF; Dong N; Han S; Zhu XM; Zhang QH; Yao YM
    Sci Rep; 2015 Nov; 5():16725. PubMed ID: 26577833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4+CD25+Foxp3+ regulatory T cells.
    Schulz VJ; Smit JJ; Bol-Schoenmakers M; van Duursen MB; van den Berg M; Pieters RH
    Toxicol Lett; 2012 Nov; 215(2):100-9. PubMed ID: 23041608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
    Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
    Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
    Sharabi A; Lapter S; Mozes E
    J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population.
    Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY
    J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of CD4+ T Cell Subsets by Euphorbia microciadia and Euphorbia osyridea Plant Extracts.
    Namdari H; Izad M; Amirghofran Z
    Iran J Immunol; 2017 Jun; 14(2):134-150. PubMed ID: 28630384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.